NCT07288684

Brief Summary

This study will determine feasibility of a chiropractor delivered virtual intervention for individuals following osteoporotic vertebral fracture. This pilot trial will have two parallel groups with a 1:1 ratio. Participants will be randomized to: 1) immediate receipt; or 2) waitlist usual care control and delayed receipt of VIVA 10 weeks post-randomization. VIVA is an intervention for people with vertebral fractures that covers four areas: pain management, safe movement, exercise, and nutrition. It includes print and video resources, and a framework for goal setting, selecting exercises, and teaching body mechanics. A chiropractor (DC) completes a virtual assessment and then leads twelve 1:1 virtual sessions (via Zoom) over eight weeks. Sessions start with brief education on a topic (e.g., safe movement, pain management, exercise, nutrition), followed by training and modeling of exercise and safe movement strategies, then goal setting, and action planning. This trial will be considered feasible if a) we recruit 14 people in eight months; b) 80% of participants complete the trial; and c) exercise adherence is 75%.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
15

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 16, 2025

Completed
3 months until next milestone

Study Start

First participant enrolled

October 20, 2025

Completed
2 months until next milestone

First Posted

Study publicly available on registry

December 17, 2025

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2026

Completed
Last Updated

December 17, 2025

Status Verified

October 1, 2025

Enrollment Period

7 months

First QC Date

July 16, 2025

Last Update Submit

December 3, 2025

Conditions

Keywords

Rehabilitation

Outcome Measures

Primary Outcomes (1)

  • Feasibility of Chiropractic Delivery

    This trial will be considered feasible if a) we recruit 14 people in eight months; b) 80% of participants complete the trial; and c) exercise adherence is 75%.

    We will consider ≥80% retention at 20 weeks acceptable. Adherence will be defined as ≥2 sessions per week of exercise at 20 weeks

Secondary Outcomes (7)

  • Participant experience

    At completion of 10 weeks.

  • Pain and Quality of Life

    Will be measured at weeks 10/20 (effectiveness) and 20 weeks (sustainability, immediate group only

  • Health-Related Quality of life

    Will be measured at weeks 10/20 (effectiveness) and 20 weeks (sustainability, immediate group only

  • Physical Performance - Balance

    Physical performance will be measured at weeks 10/20 (effectiveness) and 20 (sustainability, immediate group only).

  • Physical Performance - Sit to Stand Performance

    Physical performance will be measured at weeks 10/20 (effectiveness) and 20 (sustainability, immediate group only)

  • +2 more secondary outcomes

Study Arms (2)

Immediate Receipt of VIVA

EXPERIMENTAL

Participants receive a technology consultation 1-2 weeks prior to baseline assessment, and receive intervention in week one (immediately post-randomization). Following a virtual assessment, participants will receive twelve 1:1 virtual sessions (via Zoom) over eight weeks.

Behavioral: VIVA

Control

NO INTERVENTION

Participants receive a technology consultation 1-2 weeks prior to baseline assessment, and receive intervention in week ten (waitlist control).

Interventions

VIVABEHAVIORAL

VIVA is an intervention for people with vertebral fractures that covers four areas: pain management, safe movement, exercise, and nutrition. It includes print and video resources, and a framework for goal setting, selecting exercises, and teaching body mechanics.

Immediate Receipt of VIVA

Eligibility Criteria

Age50 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Over the age of 50 (men or post-menopausal women)
  • Have had a vertebral fracture in the past two years
  • Willing to participate in twelve (12) virtual rehabilitation sessions for 10 weeks
  • Have access to internet and a smart device with a camera and microphone

You may not qualify if:

  • Cauda equina syndrome or spinal cord injury
  • Had a traumatic fracture (i.e., car accident)
  • An active infection
  • Active inflammatory arthritis with a flare up within the past two years
  • An inability to follow two-step commands or understand instructions and are without a caregiver to support participation
  • Been participating in a similar rehabilitation program for vertebral fractures delivered by a physical therapist, exercise physiologist or kinesiologist and includes exercise
  • Any surgeries planned or health problems that might cause their health to change significantly in the next 3 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Waterloo

Waterloo, Ontario, N2L3G1, Canada

RECRUITING

MeSH Terms

Conditions

OsteoporosisSpinal Fractures

Condition Hierarchy (Ancestors)

Bone Diseases, MetabolicBone DiseasesMusculoskeletal DiseasesMetabolic DiseasesNutritional and Metabolic DiseasesSpinal InjuriesBack InjuriesWounds and InjuriesFractures, Bone

Central Study Contacts

Allison A Legg

CONTACT

Lora Giangregorio, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Outcome assessors will be blind to group allocation. Participants will not be blind to group allocation because they will know what group they are assigned to. The waitlist control was chosen based on input from persons with lived experience, who indicated that participants may be more willing to participate if there was a wait list control rather than receiving no intervention.
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
SINGLE GROUP
Model Details: We will conduct a pragmatic, pilot trial with two parallel groups with a 1:1 ratio. Participants will be randomized to: 1) immediate receipt of VIVA intervention; or 2) waitlist usual care control and delayed receipt of VIVA 10 weeks post-randomization.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 16, 2025

First Posted

December 17, 2025

Study Start

October 20, 2025

Primary Completion

June 1, 2026

Study Completion

June 1, 2026

Last Updated

December 17, 2025

Record last verified: 2025-10

Locations